LL-37 — Research Compound

LL-37 is an antimicrobial peptide commonly referenced in immunology, microbiology, and epithelial-barrier research for its role in innate immune signaling, host-defense peptide activity, and microbial-interaction models. It is frequently used in controlled laboratory settings to evaluate cell signaling, barrier-response behavior, and inflammation-related pathways under protocol-driven conditions.

What does that mean in plain English?
In research, LL-37 is mainly studied as part of the body’s first-line defense system—the way cells respond to microbes and environmental stress. Researchers use it to explore how antimicrobial peptides interact with bacteria, immune cells, and epithelial barriers in lab models, especially when studying inflammation, immune response, and surface-level defense mechanisms.

LL-37 is a naturally occurring, 37-amino-acid antimicrobial peptide derived from human cathelicidin. It acts as a frontline immune defender by directly destroying bacteria, viruses, and fungi, and modulating inflammation. It is primarily utilized in research exploring advanced wound healing, immune regulation, and biofilm disruption.

Key Benefits of LL-37 Peptide

• Broad-Spectrum Antimicrobial Defense: Destroys cell membranes of bacteria (Gram-positive and Gram-negative), fungi, and enveloped viruses while combating tough, antibiotic-resistant biofilms.
• Immune Modulation: Signals the body to recruit neutrophils, monocytes, and T-cells to infection sites to help orchestrate an appropriate immune response.
• Anti-Inflammatory Action: Neutralizes bacterial endotoxins (such as lipopolysaccharides or LPS) to prevent excessive inflammatory responses, effectively guarding against cytokine storms.
• Wound Healing and Tissue Regeneration: Promotes angiogenesis (the growth of new blood vessels) and cell migration, accelerating the repair of diabetic ulcers, burns, and surgical wounds.
• Gut and Skin Integrity: Supports the epithelial barrier and is critical for fighting chronic skin conditions, such as eczema, by lowering the risk of secondary infections.

Specifications:

• Compound: LL-37
• Format: Research compound
• Use: Research use only